Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
Bolcic F, Sede M, Moretti F, Westergaard G, Vazquez M, Laufer N, Quarleri J.
Arch Virol. 2012 Apr;157(4):703-11. Epub 2012 Jan 22.
Related citations
Discrimination of agonist and antagonist forms of CXCL10 in biological samples.
Casrouge A, Bisiaux A, Stephen L, Schmolz M, Mapes J, Pfister C, Pol S, Mallet V, Albert ML.
Clin Exp Immunol. 2012 Jan;167(1):137-48. doi: 10.1111/j.1365-2249.2011.04488.x.
Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective.
Alkhatib AA, Hilden K, Adler DG.
Dig Dis Sci. 2011 Dec;56(12):3685-8. Epub 2011 Jul 26.
Age versus clinical virological characteristics in chronic hepatitis B virus infection: a case series study in China.
Wu DL, Xu GH, Lu SM, Ma BL, Miao NZ, Liu XB, Feng JH, Liu N, Zeng QL, Hou WK, Pei L, Zhao Y.
Eur J Gastroenterol Hepatol. 2012 Apr;24(4):406-13.
Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.
Arai M, Togo S, Kanda T, Fujiwara K, Imazeki F, Yokosuka O.
Eur J Gastroenterol Hepatol. 2012 Apr;24(4):414-8.
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks.
Sarrazin C, Schwendy S, Möller B, Dikopoulos N, Buggisch P, Encke J, Teuber G, Goeser T, Thimme R, Klinker H, Boecher WO, Schulte-Frohlinde E, Prinzing R, Herrmann E, Zeuzem S, Berg T.
Gastroenterology. 2011 Nov;141(5):1656-64. Epub 2011 Jul 22.
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.
Candotti D, Lin CK, Belkhiri D, Sakuldamrongpanich T, Biswas S, Lin S, Teo D, Ayob Y, Allain JP.
Gut. 2012 Jan 20. [Epub ahead of print]
Liver stiffness predicts clinical outcome in HIV/HCV-coinfected patients with compensated liver cirrhosis.
Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Márquez-Solero M, Omar M, Macías J, Camacho A, Pérez-Pérez M, Gómez-Mateos J, Rivero A, Pineda JA; on behalf of the Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).
Hepatology. 2012 Jan 25. doi: 10.1002/hep.25616. [Epub ahead of print]
Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis.
Sancho-Bru P, Altamirano J, Rodrigo-Torres D, Coll M, Millán C, José Lozano J, Miquel R, Arroyo V, Caballería J, Ginès P, Bataller R.
Hepatology. 2012 Jun;55(6):1931-41. doi: 10.1002/hep.25614. Epub 2012 Apr 23.
Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients.
Rasmussen AL, Tchitchek N, Susnow NJ, Krasnoselsky AL, Diamond DL, Yeh MM, Proll SC, Korth MJ, Walters KA, Lederer S, Larson AM, Carithers RL, Benecke A, Katze MG.
Hepatology. 2012 Jan 25. doi: 10.1002/hep.25612. [Epub ahead of print]
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T, Amaddeo G, Restuccia A, Raffa G, Alibrandi A, Cutroneo G, Favaloro A, Maimone S, Squadrito G, Raimondo G.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25592. [Epub ahead of print]
MxA inhibits hepatitis B virus replication by interaction with core protein HBcAg.
Li N, Zhang L, Chen L, Feng W, Xu Y, Chen F, Liu X, Chen Z, Liu W.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25608. [Epub ahead of print]
A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients.
D'Ambrosio R, Aghemo A, Grazia Rumi M, Ronchi G, Donato MF, Paradis V, Colombo M, Bedossa P.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25606. [Epub ahead of print]
The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis b virus replication In Vitro.
Hoppe-Seyler K, Sauer P, Lohrey C, Hoppe-Seyler F.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25602. [Epub ahead of print]
Association between IL28B-related genetic variants and liver histopathology differs between hcv genotypes.
Rembeck K, Westin J, Lindh M, Hellstrand K, Norkrans G, Lagging M; for the NORDynamIC study group.
Hepatology. 2012 Jan 23. doi: 10.1002/hep.25598. [Epub ahead of print] No abstract available.
Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections.
Lochhead MJ, Todorof K, Delaney M, Ives JT, Greef C, Moll K, Rowley K, Vogel K, Myatt C, Zhang XQ, Logan C, Benson C, Reed S, Schooley RT.
J Clin Microbiol. 2011 Oct;49(10):3584-90. Epub 2011 Aug 24.
A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C.
Thu Thuy PT, Bunchorntavakul C, Tan Dat H, Rajender Reddy K.
J Hepatol. 2012 May;56(5):1012-8. Epub 2012 Jan 17.
Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.
Zhu H, Wong-Staal F, Lee H, Syder A, McKelvy J, Schooley RT, Wyles DL.
J Infect Dis. 2012 Feb;205(4):656-62.
Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan.
Su WJ, Liu CC, Liu DP, Chen SF, Huang JJ, Chan TC, Chang MH.
J Infect Dis. 2012 Mar;205(5):757-62. Epub 2012 Jan 19.
More lessons from the Taiwanese hepatitis B virus vaccine program.
Schwarz KB.
J Infect Dis. 2012 Mar;205(5):702. Epub 2012 Jan 19. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on